CtrlK
BlogDocsLog inGet started
Tessl Logo

tooluniverse-aging-senescence

Aging biology, cellular senescence, and longevity research. Covers senescence markers (p16/CDKN2A, SASP, SA-beta-gal), aging hallmarks, senolytic drug discovery (dasatinib+quercetin, fisetin, navitoclax), epigenetic clocks, telomere biology, and longevity GWAS. Use for senescence-pathway analysis, age-related disease genetics, senolytic-target discovery, and centenarian-genetics queries. Distinguishes correlative vs causal evidence (knockout, intervention).

68

Quality

83%

Does it follow best practices?

Run evals on this skill

Adds up to 20 points to the overall score

View guide

SecuritybySnyk

Passed

No findings from the security scan

SKILL.md
Quality
Evals
Security

Quality

Content

77%Weight 40%Scale 1-5

Reviews the quality of instructions and guidance provided to agents. Good implementation is clear, handles edge cases, and produces reliable results.

Highly actionable content with executable tool calls throughout and a coherent phased workflow supported by an evidence-grading scheme. Conciseness and progressive disclosure are the weaker dimensions: some explanatory biology could be trimmed, and the skill is a single monolithic file with no external reference split despite its length.

Suggestions

Trim tutorial-style biology explanations (e.g. the 12-hallmarks enumeration and senescence-marker caveat prose) to facts Claude would not already know, improving token efficiency.

Move detailed per-phase tool catalogs or long gene/locus reference tables into a references/ file (e.g. references/hallmarks.md) and link from SKILL.md, enabling one-level-deep progressive disclosure.

Add explicit validation checkpoints in the workflow (e.g. 'Before Phase 4, confirm the hallmark classification and evidence grade from Phases 1-3') to make the feedback loops concrete.

DimensionReasoningScore

Conciseness

Mostly efficient with executable code blocks and tight prose, but sections like the hallmarks enumeration and senescence-marker caveats explain biology Claude largely already knows and could be trimmed.

4 / 5

Actionability

Copy-paste-ready executable tool calls appear in every phase (OpenGenes, GWAS, KEGG, STRING, Reactome, DGIdb, clinical trials, PubMed) with concrete arguments and expected outputs, covering the common query cases.

5 / 5

Workflow Clarity

A clear six-phase pipeline with an explicit Phase 0 parsing step and an evidence-grading framework (T1-T4), but validation/feedback checkpoints are implicit rather than stated as 'verify before proceeding' gates.

4 / 5

Progressive Disclosure

Well-organized into phases with clear section headers, but everything is inlined into one ~180-line file with no bundle files (references/scripts/assets absent) and no signaled one-level-deep references to separate detail files.

3 / 5

Total

16

/

20

Passed

Description

88%Weight 40%Scale 1-5

Based on the skill's description, can an agent find and select it at the right time? Clear, specific descriptions lead to better discovery.

A highly specific, well-triggered description that clearly states what it covers and when to use it, with concrete domain vocabulary and an explicit cause-vs-consequence framing. Minor gaps in synonyms like 'anti-aging'/'lifespan' keep trigger and distinctiveness just below the top anchor.

DimensionReasoningScore

Specificity

Lists many concrete capabilities — senescence markers (p16/CDKN2A, SASP, SA-beta-gal), senolytic drugs (dasatinib+quercetin, fisetin, navitoclax), epigenetic clocks, telomere biology, longevity GWAS — giving comprehensive, specific coverage.

5 / 5

Completeness

Explicitly answers both 'what' (covers the listed biology and drug domains) and 'when' via the 'Use for ...' clause with concrete trigger phrases, plus a distinguishing-evidence note.

5 / 5

Trigger Term Quality

Strong natural triggers ('senescence-pathway analysis', 'senolytic-target discovery', 'centenarian-genetics queries') and good keyword coverage, but a few common user phrasings (e.g. 'anti-aging', 'lifespan') are not explicitly surfaced as trigger terms.

4 / 5

Distinctiveness Conflict Risk

Clear niche (aging/senescence) with explicit boundary guidance ('Not this skill' in the body) and a distinct evidence-grading framing, though it could overlap with adjacent disease-research skills without that body-level disclaimer.

4 / 5

Total

18

/

20

Passed

Validation

100%

Checks the skill against the spec for correct structure and formatting. All validation checks must pass before discovery and implementation can be scored.

Validation16 / 16 Passed

Validation for skill structure

No warnings or errors.

Repository
mims-harvard/ToolUniverse
Reviewed

Table of Contents

Is this your skill?

If you maintain this skill, you can claim it as your own. Once claimed, you can manage eval scenarios, bundle related skills, attach documentation or rules, and ensure cross-agent compatibility.